Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy
Authors
Keywords
-
Journal
NANO LETTERS
Volume 21, Issue 5, Pages 2094-2103
Publisher
American Chemical Society (ACS)
Online
2021-02-24
DOI
10.1021/acs.nanolett.0c04783
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds
- (2020) David K. Y. Zhang et al. Nature Protocols
- Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
- (2020) Shanshan Cheng et al. Advanced Science
- Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy
- (2020) Xianwu Wang et al. ACS Central Science
- Nanoenabled Disruption of Multiple Barriers in Antigen Cross-Presentation of Dendritic Cells via Calcium Interference for Enhanced Chemo-Immunotherapy
- (2020) Jingyi An et al. ACS Nano
- Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells
- (2020) Junya Ichikawa et al. CLINICAL CANCER RESEARCH
- Metabolic labeling and targeted modulation of dendritic cells
- (2020) Hua Wang et al. NATURE MATERIALS
- Dendritic Cells and Their Role in Immunotherapy
- (2020) Alycia Gardner et al. Frontiers in Immunology
- Engineered Cell‐Membrane‐Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity
- (2020) Yao Jiang et al. ADVANCED MATERIALS
- Expandable Immunotherapeutic Nanoplatforms Engineered from Cytomembranes of Hybrid Cells Derived from Cancer and Dendritic Cells
- (2019) Wen‐Long Liu et al. ADVANCED MATERIALS
- Bioinspired and Biomimetic Nanomedicines
- (2019) Zhaowei Chen et al. ACCOUNTS OF CHEMICAL RESEARCH
- Materials for Immunotherapy
- (2019) C. Wyatt Shields et al. ADVANCED MATERIALS
- Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades
- (2019) Xuefei Lu et al. Nature Nanotechnology
- Artificial Natural Killer Cells for Specific Tumor Inhibition and Renegade Macrophage Re‐Education
- (2019) Mei‐Zhen Zou et al. ADVANCED MATERIALS
- Rational Design of Nanocarriers for Intracellular Protein Delivery
- (2019) Xiaofei Qin et al. ADVANCED MATERIALS
- Augmentation of T-Cell Activation by Oscillatory Forces and Engineered Antigen-Presenting Cells
- (2019) Fatemeh S. Majedi et al. NANO LETTERS
- Hepatocellular Carcinoma Growth Retardation and PD-1 Blockade Therapy Potentiation with Synthetic High-density Lipoprotein
- (2019) Junyang Wang et al. NANO LETTERS
- Functional T cell activation by smart nanosystems for effective cancer immunotherapy
- (2019) Weijing Yang et al. Nano Today
- Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment
- (2019) Na Shen et al. NANO LETTERS
- Recent advances in nanosized drug delivery systems for overcoming the barriers to anti-PD immunotherapy of cancer
- (2019) Xiaochen Liu et al. Nano Today
- Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells
- (2018) Alexander S Cheung et al. NATURE BIOTECHNOLOGY
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- Facile synthesis of polylactide coarse microspheres as artificial antigen-presenting cells
- (2018) Tong Zhang et al. CHEMICAL COMMUNICATIONS
- Selected signalling proteins recruited to the T-cell receptor-CD3 complex
- (2017) Jatuporn Ngoenkam et al. IMMUNOLOGY
- Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation
- (2017) John W. Hickey et al. NANO LETTERS
- Selective in vivo metabolic cell-labeling-mediated cancer targeting
- (2017) Hua Wang et al. Nature Chemical Biology
- Long Circulation Red-Blood-Cell-Mimetic Nanoparticles with Peptide-Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer
- (2016) Jinghan Su et al. ADVANCED FUNCTIONAL MATERIALS
- Targeted Ultrasound-Assisted Cancer-Selective Chemical Labeling and Subsequent Cancer Imaging using Click Chemistry
- (2016) Hua Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy
- (2016) Dangge Wang et al. NANO LETTERS
- Chemical Tumor-Targeting of Nanoparticles Based on Metabolic Glycoengineering and Click Chemistry
- (2014) Sangmin Lee et al. ACS Nano
- Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFN
- (2014) R.-S. Soong et al. CLINICAL CANCER RESEARCH
- A carbon nanotube–polymer composite for T-cell therapy
- (2014) Tarek R. Fadel et al. Nature Nanotechnology
- Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
- (2014) Loek J. Eggermont et al. TRENDS IN BIOTECHNOLOGY
- BMP-6 in Renal Cell Carcinoma Promotes Tumor Proliferation through IL-10-Dependent M2 Polarization of Tumor-Associated Macrophages
- (2013) J.-H. Lee et al. CANCER RESEARCH
- How imiquimod licenses plasmacytoid dendritic cells to kill tumors
- (2012) Martin Holcmann et al. OncoImmunology
- Copper-free click chemistry in living animals
- (2010) P. V. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started